COMMUNIQUÉ DE PRESSE
News
-
-
-
-
COMMUNIQUÉ DE PRESSE
IGC Pharma Announces Patient Enrollment at Toronto's Baycrest in Phase 2 Trial Investigating IGC-AD1
IGC Pharma expands Phase 2 trial to Canada at Baycrest Academy for Research and Education in Toronto, Ontario, to investigate IGC-AD1 for treating agitation in Alzheimer's dementia -
-
COMMUNIQUÉ DE PRESSE
Xenetic Biosciences, Inc. Enters into Materials Transfer Agreement with Tokyo Medical University for the Advancement of Its DNase-Based Oncology Platform
Xenetic partners with Tokyo Medical University to evaluate recombinant DNase I for Ewing sarcoma treatment in preclinical model. Agreement enhances DNase program development -
-
COMMUNIQUÉ DE PRESSE
Original-Research: Deutsche Effecten- und Wechsel- Beteiligungsgesellschaft AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates recommendation on Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG to Buy with a decreased target price of €1.50. Company's financials for H1/24 in line with expectations. Management actively seeking exit options -
COMMUNIQUÉ DE PRESSE
Artprice by Artmarket félicite Gaëlle Choisne, lauréate du Prix Marcel Duchamp 2024, décerné par l'ADIAF au Centre Pompidou
La plasticienne Gaëlle Choisne remporte le Prix Marcel Duchamp 2024 et met en lumière le dynamisme de l'art contemporain français. L'ADIAF célèbre la vitalité artistique de la France sur la scène internationale -
COMMUNIQUÉ DE PRESSE
GameSquare Announces Preliminary Third Quarter 2024 Results and Provides Business Update
GameSquare Holdings, Inc. expects stellar Q3 results, with revenue estimated to surpass $26.5 million. The company raises its 2024 proforma revenue guidance to $105-110 million due to strong performance
